, Tracking Stock Market Picks
Enter Symbol:
BIODEL INC. (BIOD) [hlAlert]

down 96.63 %

BIODEL INC. (BIOD) rated Buy with price target $16 by Wedbush Morgan

Posted on: Wednesday,  Mar 25, 2009  11:25 AM ET by Wedbush Morgan

Wedbush Morgan rated Buy BIODEL INC. (NASDAQ: BIOD) on 03/25/2009, when the stock price was $20.20. Since
then, BIODEL INC. has lost 96.63% as of 12/18/2015's recent price of $0.68.
If you would have followed this Wedbush Morgan's recommendation on BIOD, you would have lost 96.63% of your investment in 2459 days.

Biodel Inc. (Biodel) is a development-stage specialty pharmaceutical company located in Danbury, Connecticut. The Company is focused on the development and commercialization of treatments for endocrine disorders, such as diabetes and osteoporosis. The Company develops product candidates by applying its formulation technologies to existing drugs in order to improve their therapeutic results. The Company?s initial development efforts are focused on peptide hormones. The Company?s advanced product candidate, VIAject, has been studied in two pivotal Phase III clinical trials for the treatment of patients with Type 1 and Type 2 diabetes. Earlier stage product candidates include VIAtab, a sublingual tablet formulation of insulin and two preclinical product candidates for the treatment of osteoporosis. The Company has developed all of its product candidates utilizing its VIAdel technology that allows the Company to study the interaction between peptide hormones and small molecules.

Since 1980, WEDBUSH has used its private equity discipline to invest in under-valued and capital constrained public and private companies that have a significant potential for appreciation. The firm invests with high quality management teams with domain expertise and expects management to retain or make a personally significant equity investment.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
3/25/2009 11:25 AM Buy
20.20 64.00
as of 12/31/2009
1 Week down  -41.72 %
1 Month down  -37.56 %
3 Months down  -56.05 %
1 YTD down  -53.26 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy